Ambri Limited
Australian biotech firm reduces annual cash expenditure by 41%
Published in Healthcare Finance, Tax and Law Weekly, September 1st, 2004
The net operating cash outflow for the quarter was $ 2.8 million. Including capital expenditure, the net cash outflow for the quarter was $3.0 million. Cash on hand at the end of the quarter was $20.2 million.
The annual result was a net operating cash outflow of $9.7 million. This was comprised of cash operating outflow of $11.1 million. Offset by cash inflows of $1.4 million in interest and other revenue.
Annual capital expenditure was $0.7 million. The total annual cash operating and capital expenditure of $11.8 million was 13% than the annualized...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Advanced Viral Research Corp.
Third installment of $3 million dollars received for shares of biopolymer stock - Advancis Pharmaceutical Corp.
Pharmaceutical company reports loss of $0.37 per share - Aksys, Ltd.
Hemodialysis firm reports loss of $0.22 per share for second quarter - Alnylam Pharmaceuticals, Inc.
Pharmaceutical firm reports on IPO, financial results - Alpharma, Inc.
Pharmaceutical firm reports 5% decrease in revenues - Amylin Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $0.42 per share - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
